The Comp Pod

Low health literacy has many impacts in workers' compensation. Andy and Ivy discuss how it delays recovery, increases costs, and worsens claim/health outcomes, as well as explore strategies for improving it.

GLP-1s are experiencing growth in workers' comp. Andy and Ivy discuss the strategies and insights the workers’ comp industry should consider when evaluating and managing these medications.

Drug shortages are no longer just a pharmacy issue but a growing claims management risk in workers' comp. Andy and Ivy discuss how shortages can contribute to more complex claims, delayed care, and higher costs.

Occupational lung diseases make up a small but significant portion of workers’ comp claims. Andy and Ivy discuss the at-risk populations and considerations for pharmacy management.

Demand for DME is rising, as are costs. Andy and Ivy discuss what's causing the increases and how product-level visibility can help contain costs.

Since 2019, the annual Workers' Compensation Industry Insights Survey has tracked the pulse of the workers' compensation industry. Andy and Ivy discuss insights from the 2026 survey, including a focus on injured worker patient engagement.

The global cancer burden continues to rise. Andy and Ivy discuss the impacts of occupational cancer on workers' comp, including costs and therapies.

More complex and costly claims have become a persistent issue in workers’ compensation. Andy and Ivy discuss what drives longer claim duration and higher costs and how to mitigate risk factors.

While more severe cases of Long COVID are uncommon, these can have a significant impact on claims costs in workers' comp. Andy and Ivy discuss how Long COVID affects disability, recovery, and pharmacy management.

A small percentage of claims are driving the majority of costs in workers’ comp. Andy and Ivy discuss these "mega claims" and how to mitigate them.